Concepedia

Sylwia A. Stopka

SA

41

Publications

1.9K

Citations

23

H-Index

2014

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

George Washington University

University of Missouri

Sylwia A. Stopka is an author at Brigham and Women's Hospital specializing in medicine, mass spectrometry, and biological mass spectrometry.

ORCID

Top concepts

Publications per year

2014–2025

41

Publications

41

Oncometabolite <scp>d</scp> -2HG alters T cell metabolism to impair CD8 <sup>+</sup> T cell function

Giulia Notarangelo, Jessica B. Spinelli, Elizabeth M. Perez et al. · Science · 2022 · 253 citations · Full text

A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma

Sharmistha Pal, Jakub Kaplan, Huy Nguyen et al. · Cancer Cell · 2022 · 130 citations · Full text

, , +9

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 130 citations · Full text

De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma

Diana D. Shi, Milan R. Savani, Michael M. Levitt et al. · Cancer Cell · 2022 · 114 citations · Full text

, , +10

Molecular Imaging of Biological Samples on Nanophotonic Laser Desorption Ionization Platforms

Sylwia A. Stopka, Charles Rong, Andrew R. Korte et al. · Angewandte Chemie International Edition · 2016 · 103 citations

Rows per page

1–5 of 41